2/25
06:24 am
cnta
Centessa Pharmaceuticals (CNTA) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Centessa Pharmaceuticals (CNTA) was upgraded by Wolfe Research to "strong-buy".
2/25
06:24 am
cnta
Centessa Pharmaceuticals (CNTA) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Centessa Pharmaceuticals (CNTA) was upgraded by Wolfe Research to "strong-buy".
2/24
08:00 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $40.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $40.00 price target on the stock.
2/24
08:00 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $40.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $40.00 price target on the stock.
2/24
07:35 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
2/24
07:35 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
2/23
04:07 pm
cnta
Centessa initiated with an Outperform at Wolfe Research
Medium
Report
Centessa initiated with an Outperform at Wolfe Research
2/23
04:07 pm
cnta
Centessa initiated with an Outperform at Wolfe Research
Medium
Report
Centessa initiated with an Outperform at Wolfe Research
1/2
08:02 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $30.00 price target on the stock.
Medium
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $30.00 price target on the stock.
1/2
07:39 am
cnta
Rating for CNTA
Medium
Report
Rating for CNTA
12/10
11:34 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
12/10
11:34 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
12/10
08:43 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $62.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $62.00 price target on the stock.